anticd16 32 blocking (Cytek Biosciences)
Cytek Biosciences is a verified supplier 
Cytek Biosciences manufactures this product 
96
Structured Review
Cytek Biosciences
anticd16 32 blocking
Anticd16 32 Blocking, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd16+cd32/Purified+Anti-Mouse+CD16+%2F+CD32/pm41932810-297-17-19
Average 96 stars, based on 1 article reviews
Anticd16 32 Blocking, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd16+cd32/Purified+Anti-Mouse+CD16+%2F+CD32/pm41932810-297-17-19
Average 96 stars, based on 1 article reviews
anticd16 32 blocking - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Labeling:Article Title: Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease. Article Snippet: .. Fluorescently labeled antibodies to cell surface antigens were diluted in PBS containing 1% FCS, 0.05% sodium azide, and 0.5 μg/mL Article Title: Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease Article Snippet: .. Fluorescently labeled antibodies to cell surface antigens were diluted in PBS containing 1% FCS, 0.05% sodium azide, and 0.5 μg/mL Staining:Article Title: Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus. Article Snippet: .. After 24 hours, cells were surfaced stained with anti CD16/CD32 and viability dye eF506 (Invitrogen), TCRβfitc and CD69- APC (BioLegend), Article Title: Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer. Article Snippet: For the tumor-associated macrophages, cells were first blocked with CD16/CD32 (TONBObiosicences, cat. no. 70-0161-U100, 1:100 dilution) and then stained with Zombie UV dye, anti-CD45-APC-Cy7, anti-CD11b-PerCP-Cy5.5 (TONBObiosciences, cat. no. 65-0112-U100, 1:100 dilution), anti-F4/80-FITC (Biolegend, cat. no. 123108, 1:100 dilution), anti-CD80-PE (TONBObiosciences, cat. no. 50-0801-U025, 1:100 dilution) and anti-CD206APC (eBioscience, cat. no. 17-2061-82, 1:100 dilution). .. For the tumor-associated macrophages, cells were first blocked with CD16/CD32 (TONBObiosicences, cat. no. 70-0161-U100, 1:100 dilution) and then stained with Article Title: Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus Article Snippet: .. After 24 hours, cells were surfaced stained with anti CD16/CD32 and viability dye eF506 (Invitrogen), TCRβ-fitc and CD69-APC (BioLegend), Article Title: Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy. Article Snippet: Anti- mouse PD1 (clone RMP1- 14, cat. BE0146, BioXCell, RRID: AB_10949053), anti- mouse IgG2a isotype control (clone 2A3, cat. BE0089, BioXCell, RRID:AB_1107769), I- 117 was synthesized according to WO2018057588 by Viva Biotech and provided by Domain Therapeutics; PAR1 antagonist RWJ 56110 (cat. 2614) from Tocris; Hydroxypropyl methylcellulose (HPMC, Sigma- Aldrich), hydroxypropyl- beta- cyclodextrin (HpBCD, ChemCruz), anhydrous Ethyl Alcohol (Eth, Commercial alcohols), and polyethylene glycol 400 (PEG 400, cat. P5402, Sigma- Aldrich). .. Deoxyribonuclease I (cat. 9003- 98- 9 Worthington), collagenase A (cat. 9001- 12- 1, Worthington), RPMI 1640 (cat. 350- 000 RL, Wisent), PBS (cat. 311- 013 CL, Wisent), EDTA (cat. 15575020, Invitrogen), Article Title: Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer Article Snippet: .. For the tumor-associated macrophages, cells were first blocked with CD16/CD32 (TONBObiosicences, cat. no. 70-0161-U100, 1:100 dilution) and then stained with Zombie UV dye, |